Home600276 • SHA
Jiangsu Hengrui Pharmaceuticals Co Ltd
¥44.65
Jan 27, 3:59:46 PM GMT+8 · CNY · SHA · Disclaimer
Stock
Previous close
¥44.64
Day range
¥44.58 - ¥45.18
Year range
¥35.51 - ¥57.53
Market cap
284.76B CNY
Avg Volume
30.56M
P/E ratio
52.54
Dividend yield
0.45%
Primary exchange
SHA
CDP Climate Change Score
D-
Financials
Income Statement
Revenue
Net income
(CNY)Sep 2024Y/Y change
Revenue
6.59B12.72%
Operating expense
4.20B13.57%
Net income
1.19B1.91%
Net profit margin
18.03-9.58%
Earnings per share
0.17
EBITDA
1.58B13.11%
Effective tax rate
11.01%
Total assets
Total liabilities
(CNY)Sep 2024Y/Y change
Cash and short-term investments
22.91B30.03%
Total assets
48.34B12.75%
Total liabilities
4.01B50.35%
Total equity
44.33B
Shares outstanding
6.27B
Price to book
6.40
Return on assets
7.34%
Return on capital
8.08%
Net change in cash
(CNY)Sep 2024Y/Y change
Net income
1.19B1.91%
Cash from operations
1.55B8.31%
Cash from investing
-349.85M-246.15%
Cash from financing
-1.37B-192.22%
Net change in cash
-180.50M-115.08%
Free cash flow
-1.25B-2,147.47%
About
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
Founded
Apr 28, 1997
Employees
19,611
Search
Clear search
Close search
Google apps
Main menu